NEWS IN BRIEF: Ruder Finn awarded Imodium Probiotica account

NEW YORK: Ruder Finn has been awarded the account for Imodium Probiotica. McNeal Consumer & Specialty Pharmaceuticals, a division of Johnson & Johnson, handed the seven-figure account to Ruder Finn's New York practice after the agency beat out Fleishman-Hillard and Rowland Communications.

NEW YORK: Ruder Finn has been awarded the account for Imodium Probiotica. McNeal Consumer & Specialty Pharmaceuticals, a division of Johnson & Johnson, handed the seven-figure account to Ruder Finn's New York practice after the agency beat out Fleishman-Hillard and Rowland Communications.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in